Investor Insight
  • Home
  • About
  • Nasdaq 100 Index
  • Products
Sign in Subscribe

REGN

A collection of 1 post
REGN

Regeneron Pharmaceuticals, Inc. (2025-12-31)

AI EQUITY RESEARCH July 02, 2026 Regeneron Pharmaceuticals, Inc. REGN Healthcare Rating Buy Price $624.72 Target $1223.57 Pitroski Score 4 Market Cap $83.60B P/E (Fwd) 18.6x P/B Ratio 2.67x ROE 14.9% Div. Yield 0.46% 52W Range $535.18 - $810.08
03 Jul 2026 9 min read
Page 1 of 1
Investor Insight © 2026
  • Sign up
Powered by Ghost